| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | sodium-independent organic anion transmembrane transporter activity | 1.94e-05 | 18 | 59 | 3 | GO:0015347 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 2.22e-05 | 193 | 59 | 6 | GO:0015276 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 2.49e-05 | 197 | 59 | 6 | GO:0022834 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | OR2W3 GPR3 OR56B1 OR6N2 SIGMAR1 CXCR4 OPN3 OR6C4 TLR2 INSR GABRQ OR8G5 GRM4 S1PR1 | 2.98e-05 | 1353 | 59 | 14 | GO:0004888 |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | OR2W3 GPR3 OR56B1 OR6N2 SIGMAR1 CXCR4 OPN3 OR6C4 OR8G5 GRM4 S1PR1 | 4.80e-05 | 884 | 59 | 11 | GO:0004930 |
| GeneOntologyMolecularFunction | G-protein activated inward rectifier potassium channel activity | 5.13e-05 | 4 | 59 | 2 | GO:0015467 | |
| GeneOntologyMolecularFunction | alpha-1,4-glucosidase activity | 8.53e-05 | 5 | 59 | 2 | GO:0004558 | |
| GeneOntologyMolecularFunction | alpha-glucosidase activity | 1.79e-04 | 7 | 59 | 2 | GO:0090599 | |
| GeneOntologyMolecularFunction | gated channel activity | 4.47e-04 | 334 | 59 | 6 | GO:0022836 | |
| GeneOntologyMolecularFunction | prostaglandin transmembrane transporter activity | 7.63e-04 | 14 | 59 | 2 | GO:0015132 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | 7.81e-04 | 140 | 59 | 4 | GO:0099094 | |
| GeneOntologyMolecularFunction | icosanoid transmembrane transporter activity | 8.79e-04 | 15 | 59 | 2 | GO:0071714 | |
| GeneOntologyMolecularFunction | glucosidase activity | 8.79e-04 | 15 | 59 | 2 | GO:0015926 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 2.30e-03 | 459 | 59 | 6 | GO:0005216 | |
| GeneOntologyMolecularFunction | inward rectifier potassium channel activity | 3.09e-03 | 28 | 59 | 2 | GO:0005242 | |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | OR2W3 GPR3 OR56B1 OR6N2 SIGMAR1 CXCR4 OPN3 OR6C4 INSR OR8G5 GRM4 CNGB1 ADCY1 S1PR1 HTT | 6.18e-06 | 1395 | 59 | 15 | GO:0007186 |
| GeneOntologyBiologicalProcess | detection of stimulus | OR2W3 OR56B1 OR6N2 CXCR4 OPN3 OR6C4 TLR2 TIMELESS OR8G5 CNGB1 | 3.45e-05 | 722 | 59 | 10 | GO:0051606 |
| GeneOntologyBiologicalProcess | disaccharide catabolic process | 4.81e-05 | 4 | 59 | 2 | GO:0046352 | |
| Domain | Gal_mutarotase_SF_dom | 2.08e-05 | 17 | 60 | 3 | IPR011013 | |
| Domain | Glyco_hydro_31_CS | 6.06e-05 | 4 | 60 | 2 | IPR030459 | |
| Domain | NtCtMGAM_N | 6.06e-05 | 4 | 60 | 2 | PF16863 | |
| Domain | Gal_mutarotase_N | 6.06e-05 | 4 | 60 | 2 | IPR031727 | |
| Domain | GLYCOSYL_HYDROL_F31_2 | 1.01e-04 | 5 | 60 | 2 | PS00707 | |
| Domain | Glyco_hydro_31_AS | 1.51e-04 | 6 | 60 | 2 | IPR030458 | |
| Domain | Glyco_hydro_31 | 2.11e-04 | 7 | 60 | 2 | IPR000322 | |
| Domain | Glyco_hydro_31 | 2.11e-04 | 7 | 60 | 2 | PF01055 | |
| Domain | GLYCOSYL_HYDROL_F31_1 | 2.11e-04 | 7 | 60 | 2 | PS00129 | |
| Domain | GPCR_Rhodpsn_7TM | 2.68e-04 | 670 | 60 | 9 | IPR017452 | |
| Domain | Trefoil | 2.81e-04 | 8 | 60 | 2 | PF00088 | |
| Domain | P_TREFOIL_1 | 2.81e-04 | 8 | 60 | 2 | PS00025 | |
| Domain | P_trefoil_CS | 2.81e-04 | 8 | 60 | 2 | IPR017957 | |
| Domain | 7tm_1 | 2.90e-04 | 677 | 60 | 9 | PF00001 | |
| Domain | G_PROTEIN_RECEP_F1_1 | 3.16e-04 | 685 | 60 | 9 | PS00237 | |
| Domain | G_PROTEIN_RECEP_F1_2 | 3.37e-04 | 691 | 60 | 9 | PS50262 | |
| Domain | GPCR_Rhodpsn | 3.40e-04 | 692 | 60 | 9 | IPR000276 | |
| Domain | P_TREFOIL_2 | 3.60e-04 | 9 | 60 | 2 | PS51448 | |
| Domain | PD | 3.60e-04 | 9 | 60 | 2 | SM00018 | |
| Domain | - | 5.48e-04 | 11 | 60 | 2 | 4.10.110.10 | |
| Domain | P_trefoil_dom | 6.56e-04 | 12 | 60 | 2 | IPR000519 | |
| Domain | OA_transporter | 6.56e-04 | 12 | 60 | 2 | IPR004156 | |
| Domain | OATP | 6.56e-04 | 12 | 60 | 2 | PF03137 | |
| Domain | MFS_dom | 9.05e-04 | 134 | 60 | 4 | IPR020846 | |
| Domain | K_chnl_inward-rec_Kir_cyto | 1.18e-03 | 16 | 60 | 2 | IPR013518 | |
| Domain | IRK | 1.18e-03 | 16 | 60 | 2 | PF01007 | |
| Domain | - | 1.18e-03 | 16 | 60 | 2 | 2.60.40.1400 | |
| Domain | K_chnl_inward-rec_Kir | 1.18e-03 | 16 | 60 | 2 | IPR016449 | |
| Domain | Pentatricopeptide_repeat | 2.46e-03 | 23 | 60 | 2 | IPR002885 | |
| Domain | Ig_E-set | 4.56e-03 | 104 | 60 | 3 | IPR014756 | |
| Domain | MFS | 5.07e-03 | 108 | 60 | 3 | PS50850 | |
| Domain | Kazal_2 | 5.96e-03 | 36 | 60 | 2 | PF07648 | |
| Pathway | REACTOME_GABA_RECEPTOR_ACTIVATION | 5.02e-05 | 60 | 48 | 4 | MM15708 | |
| Pathway | REACTOME_GABA_RECEPTOR_ACTIVATION | 5.02e-05 | 60 | 48 | 4 | M976 | |
| Pubmed | 6.11e-07 | 10 | 61 | 3 | 32544090 | ||
| Pubmed | Pathogen induction of CXCR4/TLR2 cross-talk impairs host defense function. | 3.03e-06 | 2 | 61 | 2 | 18765807 | |
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 25540325 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 35314385 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 14988150 | ||
| Pubmed | Huntingtin is a scaffolding protein in the ATM oxidative DNA damage response complex. | 3.03e-06 | 2 | 61 | 2 | 28017939 | |
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 23723373 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 10956667 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 24277524 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 12040038 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 28487514 | ||
| Pubmed | Absence and rescue of morphine withdrawal in GIRK/Kir3 knock-out mice. | 3.03e-06 | 2 | 61 | 2 | 18400906 | |
| Pubmed | Regulation of CXCR4 by the Notch ligand delta-like 4 in endothelial cells. | 3.03e-06 | 2 | 61 | 2 | 18339870 | |
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 36968271 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 33637563 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 27480812 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 20356844 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 18702733 | ||
| Pubmed | Pancreatic adenocarcinoma upregulated factor promotes metastasis by regulating TLR/CXCR4 activation. | 9.07e-06 | 3 | 61 | 2 | 20802527 | |
| Pubmed | Partial characterization of murine intestinal maltase-glucoamylase. | 9.07e-06 | 3 | 61 | 2 | 12150962 | |
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 12499858 | ||
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 25301452 | ||
| Pubmed | TLR2/CXCR4 coassociation facilitates Chlamydia pneumoniae infection-induced atherosclerosis. | 9.07e-06 | 3 | 61 | 2 | 32330088 | |
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 7702616 | ||
| Pubmed | Mammalian TIMELESS is required for ATM-dependent CHK2 activation and G2/M checkpoint control. | 9.07e-06 | 3 | 61 | 2 | 19996108 | |
| Pubmed | Identification of GIRK2-4 subunits in human esophageal smooth muscle cells. | 9.07e-06 | 3 | 61 | 2 | 21637918 | |
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 22098295 | ||
| Pubmed | Behavioral characterization of mice lacking GIRK/Kir3 channel subunits. | 9.07e-06 | 3 | 61 | 2 | 18194467 | |
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 26282174 | ||
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 9459542 | ||
| Pubmed | Molecular and cellular diversity of neuronal G-protein-gated potassium channels. | 9.07e-06 | 3 | 61 | 2 | 16339040 | |
| Pubmed | Altered neurotransmission in the mesolimbic reward system of Girk mice. | 9.07e-06 | 3 | 61 | 2 | 20557431 | |
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 15028774 | ||
| Pubmed | Co-expression of human Kir3 subunits can yield channels with different functional properties. | 1.81e-05 | 4 | 61 | 2 | 10659995 | |
| Pubmed | 1.81e-05 | 4 | 61 | 2 | 24820418 | ||
| Pubmed | Molecular properties of neuronal G-protein-activated inwardly rectifying K+ channels. | 1.81e-05 | 4 | 61 | 2 | 7499385 | |
| Pubmed | Functional analysis of the weaver mutant GIRK2 K+ channel and rescue of weaver granule cells. | 1.81e-05 | 4 | 61 | 2 | 8630252 | |
| Pubmed | 1.81e-05 | 4 | 61 | 2 | 11891065 | ||
| Pubmed | 1.81e-05 | 4 | 61 | 2 | 18760838 | ||
| Pubmed | Expression of G-protein inwardly rectifying potassium channels (GIRKs) in lung cancer cell lines. | 1.81e-05 | 4 | 61 | 2 | 16109170 | |
| Pubmed | Cell type-specific subunit composition of G protein-gated potassium channels in the cerebellum. | 1.81e-05 | 4 | 61 | 2 | 18088366 | |
| Pubmed | Context-Specific Striatal Astrocyte Molecular Responses Are Phenotypically Exploitable. | 1.81e-05 | 4 | 61 | 2 | 33086039 | |
| Pubmed | 3.02e-05 | 5 | 61 | 2 | 33402420 | ||
| Pubmed | 3.02e-05 | 5 | 61 | 2 | 19558451 | ||
| Pubmed | 3.02e-05 | 5 | 61 | 2 | 7926018 | ||
| Pubmed | 4.52e-05 | 6 | 61 | 2 | 32876667 | ||
| Pubmed | Reversal of female infertility by Chk2 ablation reveals the oocyte DNA damage checkpoint pathway. | 4.52e-05 | 6 | 61 | 2 | 24482479 | |
| Pubmed | Serum response factor is required for sprouting angiogenesis and vascular integrity. | 6.03e-05 | 43 | 61 | 3 | 18804439 | |
| Pubmed | The ATM signaling cascade promotes recombination-dependent pachytene arrest in mouse spermatocytes. | 6.32e-05 | 7 | 61 | 2 | 25768017 | |
| Pubmed | p53 and TAp63 participate in the recombination-dependent pachytene arrest in mouse spermatocytes. | 6.32e-05 | 7 | 61 | 2 | 28617799 | |
| Pubmed | The p97/VCP segregase is essential for arsenic-induced degradation of PML and PML-RARA. | 9.85e-05 | 262 | 61 | 5 | 36880596 | |
| Pubmed | Notch1 expression and ligand interactions in progenitor cells of the mouse olfactory epithelium. | 1.08e-04 | 9 | 61 | 2 | 17605079 | |
| Pubmed | 1.08e-04 | 9 | 61 | 2 | 12297500 | ||
| Pubmed | Dll4 and Notch signalling couples sprouting angiogenesis and artery formation. | 1.08e-04 | 9 | 61 | 2 | 28714968 | |
| Pubmed | 1.08e-04 | 9 | 61 | 2 | 32903671 | ||
| Pubmed | 1.33e-04 | 147 | 61 | 4 | 29576527 | ||
| Pubmed | 1.35e-04 | 10 | 61 | 2 | 19851446 | ||
| Pubmed | PRDM16 regulates arterial development and vascular integrity. | 1.65e-04 | 11 | 61 | 2 | 37324380 | |
| Pubmed | 2.33e-04 | 13 | 61 | 2 | 16403838 | ||
| Pubmed | Hypoxia-induced proteasomal degradation of DBC1 by SIAH2 in breast cancer progression. | 2.33e-04 | 13 | 61 | 2 | 35913115 | |
| Pubmed | 2.72e-04 | 14 | 61 | 2 | 20338046 | ||
| Pubmed | 2.72e-04 | 14 | 61 | 2 | 22346761 | ||
| Pubmed | 3.13e-04 | 15 | 61 | 2 | 16382105 | ||
| Pubmed | 3.13e-04 | 15 | 61 | 2 | 24449842 | ||
| Pubmed | 3.13e-04 | 15 | 61 | 2 | 33454003 | ||
| Pubmed | 3.13e-04 | 15 | 61 | 2 | 23830865 | ||
| Pubmed | 4.55e-04 | 18 | 61 | 2 | 7776974 | ||
| Pubmed | On the integration of alcohol-related quantitative trait loci and gene expression analyses. | 4.55e-04 | 18 | 61 | 2 | 15597075 | |
| Pubmed | Chloride intracellular channel 4 is required for maturation of the cerebral collateral circulation. | 4.55e-04 | 18 | 61 | 2 | 26276819 | |
| Pubmed | 4.90e-04 | 87 | 61 | 3 | 29991678 | ||
| Pubmed | 5.08e-04 | 19 | 61 | 2 | 26043024 | ||
| Pubmed | Analysis of microsatellite polymorphism in inbred knockout mice. | 5.63e-04 | 20 | 61 | 2 | 22509320 | |
| Pubmed | 5.63e-04 | 20 | 61 | 2 | 11877444 | ||
| Pubmed | 6.83e-04 | 22 | 61 | 2 | 31286141 | ||
| Pubmed | 6.83e-04 | 22 | 61 | 2 | 29634390 | ||
| Pubmed | Rare independent mutations in renal salt handling genes contribute to blood pressure variation. | 6.83e-04 | 22 | 61 | 2 | 18391953 | |
| Pubmed | Genome-wide identification of endothelial cell-enriched genes in the mouse embryo. | 7.48e-04 | 23 | 61 | 2 | 22535667 | |
| Pubmed | Structural basis for endosomal trafficking of diverse transmembrane cargos by PX-FERM proteins. | 7.57e-04 | 101 | 61 | 3 | 23382219 | |
| Pubmed | 8.15e-04 | 24 | 61 | 2 | 20935629 | ||
| Pubmed | CTDP1 regulates breast cancer survival and DNA repair through BRCT-specific interactions with FANCI. | 8.24e-04 | 104 | 61 | 3 | 31240132 | |
| Pubmed | 8.68e-04 | 1440 | 61 | 9 | 30833792 | ||
| Pubmed | 8.84e-04 | 25 | 61 | 2 | 17185339 | ||
| Pubmed | 1.19e-03 | 29 | 61 | 2 | 24003143 | ||
| Pubmed | 1.19e-03 | 29 | 61 | 2 | 32123907 | ||
| Pubmed | 1.28e-03 | 30 | 61 | 2 | 20890042 | ||
| Pubmed | Ubiquitin Ser65 phosphorylation affects ubiquitin structure, chain assembly and hydrolysis. | 1.36e-03 | 31 | 61 | 2 | 25527291 | |
| Pubmed | Interactome Analysis of Human Phospholipase D and Phosphatidic Acid-Associated Protein Network. | 1.54e-03 | 282 | 61 | 4 | 35007762 | |
| Pubmed | Ubiquitin-specific peptidase 2a (USP2a) deubiquitinates and stabilizes β-catenin. | 1.54e-03 | 33 | 61 | 2 | 30323974 | |
| Pubmed | 1.60e-03 | 285 | 61 | 4 | 32838362 | ||
| Pubmed | BioID identifies novel c-MYC interacting partners in cultured cells and xenograft tumors. | 1.71e-03 | 134 | 61 | 3 | 25452129 | |
| Pubmed | Myocardial Bmp2 gain causes ectopic EMT and promotes cardiomyocyte proliferation and immaturity. | 1.73e-03 | 35 | 61 | 2 | 29540665 | |
| GeneFamily | Potassium voltage-gated channel subfamily J | 7.43e-04 | 16 | 46 | 2 | 276 | |
| ToppCell | droplet-Trachea-nan-3m-Endothelial|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.99e-07 | 184 | 61 | 6 | fa5c3020e75fdde1363393dea97ebd99f1eae9ff | |
| ToppCell | droplet-Trachea-3m-Endothelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.99e-07 | 184 | 61 | 6 | ad520ab6bb776b5303df505b7e1afb22484f18a7 | |
| ToppCell | droplet-Trachea-nan-3m-Endothelial-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.99e-07 | 184 | 61 | 6 | 1d63cb75a89c5f3f3b9ebf7fce8cb0fd4a92b645 | |
| ToppCell | droplet-Trachea-nan-3m-Endothelial-endothelial_cell|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.99e-07 | 184 | 61 | 6 | 76caad53d55fff5acca27bf190a6de7b27437d9f | |
| ToppCell | droplet-Trachea-3m-Endothelial-endothelial_cell_of_trachea|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.99e-07 | 184 | 61 | 6 | 1fc1f0a3b4dbb085ebcc3960f67be24a108fe5b9 | |
| ToppCell | droplet-Trachea-3m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.99e-07 | 184 | 61 | 6 | 2467207aaea307873ab286f89cfc7668a227a694 | |
| ToppCell | droplet-Trachea-3m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l10|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.33e-07 | 189 | 61 | 6 | 28b9e96a5206b7fdae9b17daf05c8f5d24b6c5ec | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Lymphocytic-Proliferating_NK|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.75e-06 | 171 | 61 | 5 | 1eebd7138c3b20ddc1104f21615f9df0e776bbe6 | |
| ToppCell | droplet-Trachea-3m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l19|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.08e-06 | 182 | 61 | 5 | 840427d1c23d60482c943ff006b14007ed44d247 | |
| ToppCell | TCGA-Uvea-Primary_Tumor-Uveal_Melanoma-Epithelioid_Cell|TCGA-Uvea / Sample_Type by Project: Shred V9 | 5.64e-06 | 186 | 61 | 5 | e8580a2093eb7e50aad55ec7fada850d2fed8ae1 | |
| ToppCell | droplet-Lung-3m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_aerocyte_endothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.94e-06 | 188 | 61 | 5 | db0652f000d459493321b53239326706eace598c | |
| ToppCell | droplet-Kidney-nan-3m-Endothelial-kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.94e-06 | 188 | 61 | 5 | 67c04f446fa4528b13a381622e88eb1f314cc6d5 | |
| ToppCell | droplet-Kidney-nan-3m-Endothelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.94e-06 | 188 | 61 | 5 | 03a7f6538cfddc230c0eab10c3613929addd7e33 | |
| ToppCell | PND07-28-samps-Endothelial|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 6.10e-06 | 189 | 61 | 5 | eb2f8c8a90e5e9f6697a2d13274c94f40e1973e4 | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Endothelial|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.10e-06 | 189 | 61 | 5 | 1d4ad307c0606957dd7bf8da84450e5193cf4a50 | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Endothelial-endothelial_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.10e-06 | 189 | 61 | 5 | b952026044d5f6c0adce60cf24f6e0199e6f8757 | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Endothelial-endothelial_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.10e-06 | 189 | 61 | 5 | 25781edbd08c6e413740b796ecc8ba1934bd3aa5 | |
| ToppCell | PND07-28-samps-Endothelial-Postnatal_endothelial|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 6.10e-06 | 189 | 61 | 5 | d4a25d59d88325d3b20f4287e9b1160c82961a96 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.58e-06 | 192 | 61 | 5 | 5a0615fdc217554ccd611504b16e5d97628e207d | |
| ToppCell | COVID-19-kidney-PLVAP+EC|kidney / Disease (COVID-19 only), tissue and cell type | 7.10e-06 | 195 | 61 | 5 | a436483fec137584611f86b7a498a4dc2aa19cd3 | |
| ToppCell | Tracheal-NucSeq-Endothelial-Endothelia_vascular-VE_systemic_arterial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.10e-06 | 195 | 61 | 5 | 517af3e6784f02c382df6f5691945eefaa9ec4ae | |
| ToppCell | 368C-Endothelial_cells-Endothelial-A_(Artery)|368C / Donor, Lineage, Cell class and subclass (all cells) | 7.46e-06 | 197 | 61 | 5 | 7caa2c86dc4d50b57a7db8f7278d1588282ad6db | |
| ToppCell | Tracheal-NucSeq-Endothelial-Endothelia_vascular-VE_capillary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.46e-06 | 197 | 61 | 5 | 31bec97c3952c48031bd66a5dad16a70a61519c3 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-A_(Artery)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 7.46e-06 | 197 | 61 | 5 | 951f18f326967206adbbfc422cce9eea3d2e0854 | |
| ToppCell | Tracheal-NucSeq-Endothelial-Endothelia_vascular|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.64e-06 | 198 | 61 | 5 | f7aa809040fa9f5782b92eec1f289d690eb5c7bd | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_general_capillary-EC_general_capillary_L.2.0.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.64e-06 | 198 | 61 | 5 | 2400f8b8c51739ea2ae2b9f24f44eaeefa2bb6fc | |
| ToppCell | 343B-Endothelial_cells-Endothelial-E-|343B / Donor, Lineage, Cell class and subclass (all cells) | 7.83e-06 | 199 | 61 | 5 | bff61a784ef8bc040f5c7baabccaf7a7cddd5a31 | |
| ToppCell | Parenchymal-NucSeq-Endothelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.83e-06 | 199 | 61 | 5 | a4a9a1c2a34b5a8318a55d1211d6c8661ca9793e | |
| ToppCell | Parenchymal-NucSeq-Endothelial-Endothelia_vascular|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.83e-06 | 199 | 61 | 5 | d58edc5f74970bb26d844746184e4bae7c494d6b | |
| ToppCell | Tracheal-NucSeq-Endothelial-Endothelia_vascular-VE_pulmonary_venous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.83e-06 | 199 | 61 | 5 | 079931e7196719f22a89cfad82f452ec67219ee5 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-E|343B / Donor, Lineage, Cell class and subclass (all cells) | 7.83e-06 | 199 | 61 | 5 | 3cb1d9d9de64ed0a56c4f8d5e2fa02a13a73d8ac | |
| ToppCell | 5'-Parenchyma_lung-Endothelial|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.83e-06 | 199 | 61 | 5 | c0a1ed48bebcd85cbbffb8ac50fb0f902b97f239 | |
| ToppCell | Tracheal-10x3prime_v2-Endothelial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 8.02e-06 | 200 | 61 | 5 | 2e51195810bca8a98488a8a06c538feaa27f1f28 | |
| ToppCell | Tracheal-10x3prime_v2-Endothelial-Endothelia_vascular|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 8.02e-06 | 200 | 61 | 5 | 30dc7ffef2052ee8610cdca952ca12f240bcec50 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 8.02e-06 | 200 | 61 | 5 | a1fa6bae5a688faf488d6925cd3fad725dfa916b | |
| ToppCell | Biopsy_Control_(H.)-Endothelial|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 8.02e-06 | 200 | 61 | 5 | 6a9b6a4b4f204598290ae21c87ddb42ac95dfc4c | |
| ToppCell | LPS_IL1RA_TNF-Endothelial|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 8.02e-06 | 200 | 61 | 5 | d01cec331be3b03cef80e9536fc531285bcf00f6 | |
| ToppCell | Posterior_cortex-Endothelial-ENDOTHELIAL_STALK|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 4.44e-05 | 143 | 61 | 4 | 35d3652680c4dddd293301595d813161c66e5673 | |
| ToppCell | Adult-Immune-B_cell-D231|Adult / Lineage, Cell type, age group and donor | 7.38e-05 | 163 | 61 | 4 | 4f5821299b265663c7d0352b28285f56e1988841 | |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_B-B_lineage-immature_B_cell|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 7.55e-05 | 164 | 61 | 4 | 69b6566fb88c7449b7ab9056b57508cb6a1aa2af | |
| ToppCell | PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.55e-05 | 164 | 61 | 4 | 249d8f75a64bce7db52ce0c563f496b9edf602a6 | |
| ToppCell | 367C-Myeloid-Monocyte-CD16+_Monocyte|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 7.55e-05 | 164 | 61 | 4 | 1aff83fc73b4e41e6f0d4b04dbca153bcc7a3518 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.73e-05 | 165 | 61 | 4 | a74751e0ec857aa974bec04ccc747c004a8f6e01 | |
| ToppCell | Ionocyte|World / shred by cell class for turbinate | 7.73e-05 | 165 | 61 | 4 | 0cb2199b87f17ece743fb2652b2f448dfa78ae0b | |
| ToppCell | 367C-Myeloid-Monocyte-CD16+_Monocyte|367C / Donor, Lineage, Cell class and subclass (all cells) | 7.92e-05 | 166 | 61 | 4 | 430d604f5bef9fae20dc81492e6695616f6701a3 | |
| ToppCell | Control-Lymphocytic_B-B_cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.10e-05 | 167 | 61 | 4 | a15a70d3837b31cc83a2a9e3f1bbfd77a95f2312 | |
| ToppCell | Control-Lymphocytic_B|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.10e-05 | 167 | 61 | 4 | 956da82394fd6a9f45fc2031796f12cc889542cd | |
| ToppCell | Control-Lymphocytic_B-B_cells-B-cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.10e-05 | 167 | 61 | 4 | 69ed8a4a507190a1a66c4baf1f3e9be21ada39d8 | |
| ToppCell | Control-B_cells-Activated_B_cells|Control / group, cell type (main and fine annotations) | 8.29e-05 | 168 | 61 | 4 | a7159a35fe37f8c241cf8d391debe271e0698105 | |
| ToppCell | LPS-IL1RA+antiTNF-Lymphocytic_B-B_cells-B-cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.29e-05 | 168 | 61 | 4 | eeb381b62c7ba263af96de1194ed59e57b6ca3ae | |
| ToppCell | LPS-IL1RA+antiTNF-Lymphocytic_B-B_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.29e-05 | 168 | 61 | 4 | 063d0368d656962b335154c230bdcd9236e7c9ad | |
| ToppCell | LPS-IL1RA+antiTNF-Lymphocytic_B|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.29e-05 | 168 | 61 | 4 | a7c4251d8a83bc30196a444028a35c17c24dc291 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.48e-05 | 169 | 61 | 4 | c7fc3a8c44f07c557b60d469717b66e2f5863d38 | |
| ToppCell | LPS-IL1RA-Lymphocytic_B-B_cells-B-cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.68e-05 | 170 | 61 | 4 | 92e0873f618b2fa60c4d555b10f234d5cbcf3325 | |
| ToppCell | LPS-IL1RA-Lymphocytic_B-B_cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.68e-05 | 170 | 61 | 4 | c181991f933b779f99afc3782f292306f209e2ac | |
| ToppCell | LPS-IL1RA-Lymphocytic_B|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.68e-05 | 170 | 61 | 4 | 56284fbfd1e53f67c8c0b7fba64505a4002adba2 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_bronchial_vessel-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.88e-05 | 171 | 61 | 4 | 1ae4b6a25bc9c1065cf5d95998ebcc70aee21ab5 | |
| ToppCell | Adult-Immune-B_cell-D175|Adult / Lineage, Cell type, age group and donor | 8.88e-05 | 171 | 61 | 4 | 355a246f3395900342d400f6f7c6640cba0d4d5d | |
| ToppCell | E12.5-Endothelial-proliferative_endothelial_cell-proliferative_endothelial_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 9.08e-05 | 172 | 61 | 4 | ba99688e9f46671deccf824b1e77c6db0742d7df | |
| ToppCell | E12.5-Endothelial-proliferative_endothelial_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 9.08e-05 | 172 | 61 | 4 | 2136170f6e1204734cec7dbf7b32e7d5179b92b5 | |
| ToppCell | control-Lymphocytic-B_cells_2|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 9.29e-05 | 173 | 61 | 4 | 95af11b7d6c7dcd470943e5bdc56bed7a134e358 | |
| ToppCell | LPS-antiTNF-Lymphocytic_B|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.50e-05 | 174 | 61 | 4 | cc493654ea3517bc6a145c7f787f304929636f86 | |
| ToppCell | LPS-antiTNF-Lymphocytic_B-B_cells-B-cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.50e-05 | 174 | 61 | 4 | 9eb3504f9340517ef5d056503044fbdb9ffeb714 | |
| ToppCell | LPS-antiTNF-Lymphocytic_B-B_cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.50e-05 | 174 | 61 | 4 | b4c2d1c029fcd0d4926aa79a5b789c713919dcf3 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Endothelial-blood_vessel_EC-Fetal_venous_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.50e-05 | 174 | 61 | 4 | 6b5ff1cc5fe6705f7ea70b5a892dfbf91e32288d | |
| ToppCell | 368C-Endothelial_cells-Endothelial-D|368C / Donor, Lineage, Cell class and subclass (all cells) | 9.71e-05 | 175 | 61 | 4 | c4088b5f9fa145869cf5dd8bee7680b1c8fada42 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-D-|368C / Donor, Lineage, Cell class and subclass (all cells) | 9.71e-05 | 175 | 61 | 4 | ca0d3e3a0a271cccdd3881b055fecb626712478d | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Gkn3_(Gkn3)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 9.76e-05 | 65 | 61 | 3 | c736a773a1b9cb16b51849a3bf0ccd9aeec7b342 | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Gkn3_(Gkn3)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 9.76e-05 | 65 | 61 | 3 | 8f7eac868f1605830cc97d9d1676f3ebff47d49b | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Gkn3_(Gkn3)--|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 9.76e-05 | 65 | 61 | 3 | 350f33bcc5924d7e3c3318391d33a984763fe206 | |
| ToppCell | Adult-Immune-B_cell|Adult / Lineage, Cell type, age group and donor | 9.92e-05 | 176 | 61 | 4 | 4aa00dcde907ad83d3aa4bb10439b7b5c4be1e5d | |
| ToppCell | facs-Pancreas-Endocrine-18m-Endothelial-endothelial_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.92e-05 | 176 | 61 | 4 | 9ddf87e586d2378984cd007c60f7dc254845f8f3 | |
| ToppCell | facs-Pancreas-Endocrine-18m-Endothelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.92e-05 | 176 | 61 | 4 | e987e741fcf1bed8598a5060700efd3018f8123b | |
| ToppCell | Control-B_cells|Control / group, cell type (main and fine annotations) | 9.92e-05 | 176 | 61 | 4 | 9125caa27bf790f6b1b960a86c09b4bcb1b58641 | |
| ToppCell | Control-B_cells-B_cells|Control / group, cell type (main and fine annotations) | 9.92e-05 | 176 | 61 | 4 | d2c353783bd78dc24f28e00d917b88d8294fb5df | |
| ToppCell | facs-Pancreas-Endocrine-18m-Endothelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.92e-05 | 176 | 61 | 4 | 92ebcea9b2b22601234b76d7a98f0410b905a87b | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.92e-05 | 176 | 61 | 4 | 5e46a09a36b9645b1b1fcb0b64bd0898561af3a9 | |
| ToppCell | LPS_only-Lymphocytic_B-B_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.01e-04 | 177 | 61 | 4 | c82332c5f656aa26513e4f7525d5d4d733019725 | |
| ToppCell | LPS_only-Lymphocytic_B|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.01e-04 | 177 | 61 | 4 | 5ed65e08d773d157840317c72e0d43c261d438d4 | |
| ToppCell | LPS_only-Lymphocytic_B-B_cells-B-cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.01e-04 | 177 | 61 | 4 | 8a955a7ab84c434f9ad4b467246b8be3cb479406 | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.01e-04 | 177 | 61 | 4 | 0e74980a7686c31fcf1476b8f19a3392541df240 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-B_cells-Immature_B|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.04e-04 | 178 | 61 | 4 | 2e51c1596022b7047994ee13c18375bad19a54a5 | |
| ToppCell | droplet-Heart-4Chambers-18m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-04 | 178 | 61 | 4 | ba2f0585626988b511046630bc16be5c5fec3fb2 | |
| ToppCell | droplet-Heart-4Chambers-18m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-04 | 178 | 61 | 4 | 93ce73f8bcec63ebf86fabb546f88400e8f06465 | |
| ToppCell | COVID-19-kidney-PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.08e-04 | 180 | 61 | 4 | 493cf8d1a8f2a1ed2672f394a0338b110fd81d88 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.08e-04 | 180 | 61 | 4 | 162cec1734e560c068cd61717e40e18dcf92308c | |
| ToppCell | Endothelial-A-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 1.08e-04 | 180 | 61 | 4 | 4c3376169770ee9f9283daae44c17f35e46bfd19 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.08e-04 | 180 | 61 | 4 | 33c86c22ba877358cd8c1e39b5c0b3dc3a45b7dd | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.11e-04 | 181 | 61 | 4 | 4d7793026373cbcf04b15c77f95f1025d07d4c00 | |
| ToppCell | droplet-Lung-3m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.11e-04 | 181 | 61 | 4 | 2c44c41b4e8a75ebdbaeb0c6cc5a03f17c44758c | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.11e-04 | 181 | 61 | 4 | 92d44892bb15771f0ab5fe61879b204b0acbd9b3 | |
| ToppCell | droplet-Mammary_Gland-nan-18m-Endothelial-nan|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.11e-04 | 181 | 61 | 4 | 2e15c46e8260bb04d8264478c19a707221996026 | |
| ToppCell | 10x3'2.3-week_14-16-Endothelial-stroma-proliferating_EC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.13e-04 | 182 | 61 | 4 | 997d37ca2af661c92a56add888762724dfccc890 | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-04 | 182 | 61 | 4 | 81279877b920b5a1bc991a07d3031d6458700fe3 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.15e-04 | 183 | 61 | 4 | 3427f3cbe6ea81709750e7dd3ff378f03ae65eab | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-kidney_loop_of_Henle_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-04 | 183 | 61 | 4 | 03c7e69136d5a3b9c5b2c91733e9b1c791f45c49 | |
| ToppCell | (4)_Endothelial_cells-(40)_EC-arterial|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 1.18e-04 | 184 | 61 | 4 | 7e1a2971321ddcfa00d78d3e3ba7960e532f9392 | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_mature-endo_arterial_(9)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.18e-04 | 184 | 61 | 4 | a809b0fa52df8a159f60f87eefcef61220af5e34 | |
| ToppCell | droplet-Heart-4Chambers-21m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-04 | 184 | 61 | 4 | f17d713af4a97dff4eeeab24c405677ef2ffcf84 | |
| ToppCell | facs-Trachea-nan-24m-Endothelial|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-04 | 185 | 61 | 4 | dec60254204014083ff3b4aec0cc75410950a486 | |
| Computational | Neighborhood of LTK | 1.95e-05 | 46 | 38 | 4 | GCM_LTK | |
| Computational | Neighborhood of RING1 | 4.28e-05 | 112 | 38 | 5 | GCM_RING1 | |
| Computational | Neighborhood of FANCC | 7.52e-05 | 126 | 38 | 5 | GCM_FANCC | |
| Drug | Loperamide hydrochloride [34552-83-5]; Up 200; 7.8uM; PC3; HT_HG-U133A | 1.15e-05 | 189 | 61 | 6 | 4672_UP | |
| Drug | baclofen | 1.22e-05 | 191 | 61 | 6 | CID000002284 | |
| Drug | Revivon | 1.33e-05 | 54 | 61 | 4 | CID000026644 | |
| Drug | Norgestrel-(-)-D [797-63-7]; Down 200; 12.8uM; PC3; HT_HG-U133A | 1.45e-05 | 197 | 61 | 6 | 3708_DN | |
| Drug | Ribavirin [36791-04-5]; Down 200; 16.4uM; MCF7; HT_HG-U133A | 1.45e-05 | 197 | 61 | 6 | 6018_DN | |
| Drug | Proguanil hydrochloride [637-32-1]; Up 200; 13.8uM; MCF7; HT_HG-U133A | 1.50e-05 | 198 | 61 | 6 | 3505_UP | |
| Drug | arcaine | 1.72e-05 | 19 | 61 | 3 | CID000002227 | |
| Drug | Copper silicide | 2.11e-05 | 3 | 61 | 2 | CID006336988 | |
| Drug | Acarbose | 4.22e-05 | 4 | 61 | 2 | DB00284 | |
| Drug | nimbidiol | 4.22e-05 | 4 | 61 | 2 | ctd:C496111 | |
| Disease | hemangioblastoma (is_marker_for) | 2.19e-05 | 4 | 57 | 2 | DOID:5241 (is_marker_for) | |
| Disease | 1,5 anhydroglucitol measurement | 2.41e-05 | 29 | 57 | 3 | EFO_0008009 | |
| Disease | renal cell carcinoma | 7.44e-05 | 42 | 57 | 3 | EFO_0000681 | |
| Disease | Prenatal Exposure Delayed Effects | 2.39e-04 | 12 | 57 | 2 | C0033054 | |
| Disease | lymphocyte count | NFE2L3 CXCR4 OPN3 ATM KLHL14 NIBAN3 S1PR1 ARHGEF15 HTT ITPR2 | 4.49e-04 | 1464 | 57 | 10 | EFO_0004587 |
| Disease | pre-malignant neoplasm (biomarker_via_orthology) | 4.89e-04 | 17 | 57 | 2 | DOID:0060071 (biomarker_via_orthology) | |
| Disease | atopic dermatitis (is_implicated_in) | 1.16e-03 | 26 | 57 | 2 | DOID:3310 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ALYAVLSITYRLLLT | 41 | Q8NFU0 | |
| LSITYRLLLTQEQRY | 46 | Q8NFU0 | |
| YSSVLILAFISLDRY | 121 | P61073 | |
| RYKQLLTYIRSAVTR | 91 | P61201 | |
| SYAALLTKTNRIYRI | 666 | Q14833 | |
| TSTLTRLRYSYRVIC | 161 | Q9NR61 | |
| SYLRSLRLLTDTFVL | 431 | O94989 | |
| LSSRYLEVLINLYRT | 316 | Q6ZSC3 | |
| SRTRRYYLSVIIVSA | 166 | Q16625 | |
| FYSFSELLRLTRTLL | 876 | Q14571 | |
| TYRYLTDLFTTLVDL | 41 | Q92806 | |
| GYTLLTSQREYLRLL | 151 | Q86XR2 | |
| NITELRRIYSFYSSL | 416 | P0C881 | |
| NITELRRIYSFYSSL | 416 | B2RC85 | |
| SSYIFIIASILRIRY | 251 | Q8NG78 | |
| ILNYIYSSKIVRVRS | 81 | Q86T24 | |
| TYLAVLYDSTRISLF | 486 | Q9NXD2 | |
| RETYRYLTDIFTTLV | 71 | P48051 | |
| DSRLAYYETTLNLTL | 116 | Q9UN88 | |
| SRTVLQTRYTLLPYL | 2501 | O43451 | |
| LYRVTCDQTYLLRSL | 116 | Q9NS86 | |
| LSYSYIVRAVLQIRS | 216 | Q7Z3T1 | |
| LSRYYLTDLQVSLIR | 566 | Q9Y4A8 | |
| SYILILYSVLRLNSA | 226 | Q8NGI3 | |
| SVYLYLSSLRESCTI | 251 | Q8WWY8 | |
| DQLRLITSLVYLYSR | 371 | Q96KJ4 | |
| ISGYLKIRRSYALVS | 391 | P06213 | |
| YTYIIRTILRIPSAQ | 216 | Q8NGE1 | |
| SLLAITVDRYLSLYN | 126 | P46089 | |
| LTRTVSFSVYLKRSY | 481 | Q3SYG4 | |
| LTIRLSSRYRYGQLI | 196 | Q15645 | |
| TVERLSQTYLYRASL | 746 | Q9H158 | |
| IVSIATLTVLAYERY | 126 | Q9H1Y3 | |
| STSDYLVVYLRLLTS | 166 | Q96FW1 | |
| YSLTLDRTLAIVYSV | 266 | Q8NGY6 | |
| RSLESVYSLYPTLSR | 2161 | Q13315 | |
| TSYILVLELSGYTRT | 761 | Q08828 | |
| VTLTAYIVTSLLGYR | 1046 | Q6YHK3 | |
| SVSTITRIYRGYNLL | 976 | P42858 | |
| RLVLEYLYTANVTLS | 136 | Q9P2G3 | |
| YLALRISYSLFTALR | 21 | Q53GQ0 | |
| ISVSRLETVISSIYY | 76 | O60941 | |
| LLVYLSVRYAGRRLT | 391 | Q9Y694 | |
| SIVILYCRIYSLVRT | 216 | P21453 | |
| AEYLILHLISTVYTR | 366 | Q9BTE3 | |
| LSYNDYLSRLTVVVL | 286 | Q9BQS2 | |
| TTERILYYSGYTRSL | 86 | Q969S9 | |
| LRTYLSAEYNLETSR | 281 | Q7Z6B7 | |
| YTLRSYARGLRLELT | 201 | Q99720 | |
| SGYLSSVITTIERRY | 146 | Q9H2Y9 | |
| SVVYRLDSLTTLYLR | 186 | Q9UQ13 | |
| LVKSSRQYLTIRYTL | 681 | P14410 | |
| SYLRLTYERLLQQTS | 1441 | O15047 | |
| TVITSLERRYDLHSY | 126 | Q96BD0 | |
| SILSKAYVYRVIRTT | 781 | Q14028 | |
| STVVRAYVLLLRSYQ | 701 | Q9UNS1 | |
| ITERLTSYNLEYSLL | 201 | Q8NHY6 | |
| SSTALLYSKRLITYR | 371 | O15164 | |
| IYDSLLPIRSSILYR | 306 | Q7RTY8 | |
| YYAAQLLITLSALRS | 206 | Q8N661 | |
| SSSAYLLFYERVLSR | 491 | Q70CQ3 | |
| YDLSTLYSLTERVKR | 326 | O60603 |